Skip to content
drillr.ai
Sign up

DAWN

Day One Biopharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$21.53
+0.00%
Ask drillr

  • Jul 8, 2026, 00:00 UTC

    Aura Biosciences appointed Jeremy Bender as a Class II director effective July 7, 2026.